Stem Cell/Bone Marrow Transplantation

Stem cell transplantation also known as Bone Marrow transplantation is mainly used to treat blood cancer. Marrow is the soft, spongy tissue inside bones. It contains cells called hematopoietic stem cells. These cells can turn into several other types of cells. They can turn into more bone marrow cells and they can also turn into any type of blood cell. Certain cancers and other diseases keep hematopoietic stem cells from developing normally. A stem cell transplant gives new stem cells. The new stem cells can make new and healthy blood cells. An Autologous Transplant is a type of transplant that uses the person's own stem cells which are preserved earlier and used later. In an allogeneic transplant procedure the patient receives bone marrow or peripheral blood stem cells from another person. Umbilical cord blood is an alternative hematopoietic stem cell source for patients with hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation. Human leukocyte antigen haplotype-mismatched transplant for hematological neoplasms is controversial.

  • Autologous transplant
  • Allogeneic transplantation
  • Umbilical cord blood transplant
  • Parent-child transplant
  • Haplotype mismatched transplant

Related Conference of Stem Cell/Bone Marrow Transplantation

March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK
March 24-25, 2025

10th World Conference on Breast and Cervical Cancer

Paris, France
April 07-08, 2025

15th World Congress on Breast Cancer

Vancouver, Canada
June 16-17, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
July 14-15, 2025

5th World Congress on Breast Cancer

Berlin, Germany
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain

Stem Cell/Bone Marrow Transplantation Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in